Call Today for a FREE Confidential Case Review - Toll-Free 24/7 (866) 920-0753

Natesto (Nasal Testosterone) Approved Amid FDA Safety Study

Natesto (Nasal Testosterone) Approved Amid FDA Safety Study

May 30, 2014 — Trimel Pharmaceuticals has received approval for Natesto, the first-ever nasal testosterone spray for the treatment of hypogonadism (low testosterone).

Natesto is administered with two spritzes three times per day. Each spritz contains 5.5-mg of testosterone, bringing the total daily dose to 33-mg. The most common side effects included nasal irritation, scabs, runny nose, upper respiratory tract infection, and more.

The FDA approved Natesto after a 90-day Phase III clinical trial involving 306 men with hypogonadism found that 90% of men on Natesto had normal testosterone levels by the end of the study.

Testosterone replacement therapy has never been more popular. The approval of Natesto comes at a time when men have a wide variety of options — topical gel, underarm liquid, injections, subcutaneous pellets, patches, and even an oral buccal tablet. The advantages of Natesto over topical testosterone gels like AndroGel is that skin-to-skin contact is less likely to spread testosterone to women and children.

Despite a growing number of testosterone treatment options, researchers still do not fully understand the long-term risks and benefits. This is concerning, because testosterone therapy is a lifetime commitment. The body stops producing its own (albeit low) levels of testosterone in response to supplemental drugs.

In January, the FDA opened a safety investigation into possible cardiovascular risks of testosterone therapy. Testosterone can elevate the number of red blood cells, “thicken” the blood, and elevate blood pressure. Several recent studies have raised concern that this could lead to a deadly heart attack or stroke, especially among older men. 

Do I have a Testosterone Therapy Lawsuit?

The Schmidt Firm, PLLC is currently accepting testosterone therapy induced injury cases in all 50 states. If you or somebody you know has been injured by a heart attack, stroke, or blood clot, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

Free Case Evaluation

The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiff’s law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firms reputation for providing personal attention to each and every client we represent.

No matter what type of case you have, you may contact us with confidence by filling out the email contact form below or calling us directly by dialing toll free 24 hrs/day (866) 920-0753.

*
*
*